Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy. | Front Immunol | 2023 | 37359555 | PubTator, text mining | PubMed |
| Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs. | Sci Rep | 2023 | 37344505 | PubTator, text mining | PubMed |
| T cells in health and disease. | Signal Transduct Target Ther | 2023 | 37332039 | PubTator, text mining | PubMed |
| Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. | J Ovarian Res | 2023 | 37322531 | PubTator, text mining | PubMed |
| Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells. | J Hematol Oncol | 2023 | 37316891 | PubTator, text mining | PubMed |
| Renal cell carcinoma escapes NK cell-mediated immune surveillance through the downregulation of DNAM-1. | Cancer Commun (Lond) | 2023 | 37314951 | PubTator, text mining | PubMed |
| Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies. | Essays Biochem | 2023 | 37313600 | PubTator, text mining | PubMed |
| SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. | Front Cell Dev Biol | 2023 | 37313439 | PubTator, text mining | PubMed |
| Crosstalk between the gut microbiota and innate lymphoid cells in intestinal mucosal immunity. | Front Immunol | 2023 | 37304260 | PubTator, text mining | PubMed |
| An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood. | Regen Ther | 2023 | 37303464 | PubTator, text mining | PubMed |
| Comparison of the different anti-CD16 antibody clones in the activation and expansion of peripheral blood NK cells. | Sci Rep | 2023 | 37302991 | PubTator, text mining | PubMed |
| Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease. | Int J Mol Sci | 2023 | 37298547 | PubTator, text mining | PubMed |
| NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential. | Int J Mol Sci | 2023 | 37298470 | PubTator, text mining | PubMed |
| A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37297016 | PubTator, text mining | PubMed |
| Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors. | Cancers (Basel) | 2023 | 37296855 | PubTator, text mining | PubMed |
| Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis. | Front Immunol | 2023 | 37292210 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis. | Front Immunol | 2023 | 37287972 | PubTator, text mining | PubMed |
| Editorial: ILC checkpoints: expression and functions in physiological and pathological conditions. | Front Immunol | 2023 | 37283753 | PubTator, text mining | PubMed |
| Natural killer cells- from innate cells to the discovery of adaptability. | Front Immunol | 2023 | 37275911 | PubTator, text mining | PubMed |
| Regulatory NK cells in autoimmune disease. | Iran J Basic Med Sci | 2023 | 37275764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=15